Catalog No. (SJDT338K)  •  US $4,850  •  September 2023


Greystone Research Associates is pleased to announce the publication of a new market assessment. Self-administered Injectable Drug Therapies and Markets is a comprehensive evaluation and analysis of the technology, products and participants providing the driving force behind this evolving segment of the healthcare sector. The study is designed to provide drug company decision makers, drug delivery developers, device designers, healthcare marketers, and supply chain participants with a detailed understanding of the economics, technologies, opportunities for injection devices that are designed for patient self-administration. Provider organization business managers, healthcare administrators and investors will also benefit from this study.

Evolution in Therapeutic Care

Because of the ongoing need for repeat dosing posed by chronic diseases, these indications represent significant drug volume and revenue opportunities, while simultaneously challenging the industry to develop products that meet the unique needs of the non-professional caregiver. For drugs designed to be administered by the patient, therapy-specific packaging is improving adherence and treatment outcomes. In the area of delivery, reusable injection devices designed to accept prefilled syringes or drug cartridges are improving ease-of-use and increasing the alternative device share of the growing self-injection market.


Numerous graphs, charts, tables and visualizations complement the analysis


Forecasts, projections of future market activity are derived using standard modeling and statistical techniques.


What You Will Learn

  • Provides detailed analysis of injectable drug products, drug delivery and device strategies, and product development factors.
  • Assesses key markets, market dynamics and market demographics.
  • Analyzes therapeutic demand drivers and evaluates injectable drug products in nine key therapeutic segments.
  • Provides market data and forecasts.
  • Profiles market sector participants, their product development activities, business strategies, and corporate alliances and affiliations
  • Assesses the importance of alliances and partnerships on drug product commercialization.
  • Evaluates the impact of economic, technology, and regulatory factors

Table of Contents – Handheld Devices for High Viscosity Injectables

Executive Summary

The Market Opportunity

Delivery Market Dynamics
The Economics of Injectable Drugs
What’s Driving the Growth in
Injectable Devices?
Prefilled Syringes Proliferating
The Prefilled Syringe Supply Chain
The Trend toward Self-
Shifting Demographics
Innovation in Disposable Device
Proliferation of Biological Drugs

Therapeutic Monoclonal Antibodies

Injectable Drug Device Summaries
Single Fixed Dose
Variable Dosing
High Viscosity
Dual Chamber

Wirelessly Enabled Autoinjectors
Selected Product Specific Autoinjectors

Autoinjector Device Design Factors

Material Selection Issues
Part Counts and Device Cost
Safety Features
Needle Insertion Depth
Failsafe Activation
Dose Inspection/Injection Confirmation

Market Factors
Lyophilized Drugs/Reconstitution
Human Engineering/Ergonomics

Pen Injectors
Pen Injector Design Selection
Standardized Pen Platforms
Custom Pen Designs
Reusable Pens
Dual Chamber Pens

Commercial Pen Products
Detailed Profiles of 23 Devices

Wearable Devices – Analysis and Assessments
Libertas (Becton Dickinson)
SmartDose (West Pharmaceuticals)
Neulasta OnPro Injector (Insulet/Amgen)
YpsoDose (Ypsomed)
Electronic Semi-disposable
eLVD Patch Pump (Elcam)

Emerging Technology
Wireless Data

Injectable Drug Market Analysis and Forecasts

Autoimmune Diseases
Rheumatoid Arthritis
Multiple Sclerosis

Market Factors
Regulatory Issues
Device Branding
Patient Adherence and Ease of Use
Healthcare Economics

Company Profiles


Self-administered Injectable Drug Therapies


Order Online





This Report is also available from Global Information, Inc.